8
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 261-279 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Intranasal immunization with bacterial polysaccharide containing liposomes enhanced anti-gen-specific pulmonary secretory antibody response. ABRAHAM, E., Vaccine, 1992, 10, (7), 461–468.
  • Activity of liposomal interleukin-2 in vitro. ADIBZADEH, M., WEDER, H. G., REHBEIN, A., SCHWULERA, U., OBERMEIER, J., and PAwELEc, G., Mol. Biother., 1992, 4, (1), 24–28.
  • Release behavior from microcapsules of chloroquine phosphate treated with polymerized latex of Landolphia dulcis. Anixwu, M. U., STP Pharma Sci., 1992, 2, (3), 285–289.
  • Influence of plasticizers on the values of operational voltages of microencapsulated liquid crystals. ADOMENAS, P., BUIVYDAS, M., VAREIKIS, A., and PAMEDITYTE, V., Mol. Cryst. Liq. Cryst. Sci. Technol., Sect. A, 1992, 215, 153–160.
  • Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. AHMED, I., and ALLEN, T. M., Cancer Res., 1992, 52, (17), 4817–4820.
  • Preparation and release kinetics of ethyl cellulose walled microcapsules containing phenazopyridine hydrochloride dispersed in poly(methyl methacrylate) matrixes. AHMED, S. M., SALEH, S. I., ABDEL RAHMAN, S. I., KHIDR, S. H., ABouTALEB, A. E., and Au, A. M., STP Pharma Sci., 1992, 2, (2), 205–209.
  • Chronic toxicity of microencapsulated bromodichloromethane administered in the diet to Wistar rats. AIDA, Y., YASUHARA, K., TAKADA, K., KUROKAWA, Y., and TOBE, m., y. Toxicol. Sci., 1992, 17, (2), 51–68.
  • Some factors affecting properties and dissolution behavior of tableted furosemide micro-spheres. AKBuGA, J., Pharmazie, 1992, 47, (2), 128–131.
  • Design of liposome to improve encapsulation efficiency of gelonin and its effect on immunoreactivity and ribosome inactivating property. ALAN', A., BHURI, S. R., MAVII,A, A. K., and SINGH, V., Mol. Cell. Biochem., 1992, 112, (2), 97–107.
  • Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells. ALINO, S. F., UNDA, F. J., IRUARRIZAGA, A., ALFARO, J., HII,ARIO, E., PEREZ-YARZA, G., BOBADILLA, M., and LEJARRETA, M., Lab. Invest., 1992, 66, (6), 671–679.
  • Poly(lactic acid) microspheres as immunological adjuvants for orally delivered cholera toxin B subunit. ALMEIDA, A. J., ALPAR, H. O., WILLIAMSON, D., and BROWN, M. R. W., Biochem. Soc. Trans., 1992, 20, (4), 316S
  • Is there a relationship between regional microsphere distribution and hepatic arterial blood flow? ANDERSON, J. H., ANGERSON, W. J., WILLMOTT, N., KERR, D. J., McARDLE, C. S., and COOKE, T. G., Br. J. Cancer, 1992, 66, (2), 287–289.
  • Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration. ANDERSON, P. M., KATSANIS, E., SENCER, S. F., HASZ, D., OctioA, A. C., and BOSTROM, B., y. Immunother., 1992, 12, (1), 19–31.
  • Triggered release of hydrophilic agents from plasmalogen liposomes using visible light or acid. ANDERSON, V. C., and THOMPSON, D. H., Biochim. Biophys. Acta, 1992, 1109, (1), 33–42.
  • Highly stable polymeric liposomes based on a diene-containing phosphatidylcholine. ANIKIN, A. V., CHUPIN, V. V., ANIKIN, M. V., SEREBRENNIKOVA, G. A., and EVSTIGNEEVA, R. P., Dokl. Akad. Nauk. SSSR, 1991, 321, (5), 1103–1105.
  • Expansion of microspheres. ANON., Res. Discl., 1992, 337, 402.
  • Suppression of ischemia-reperfusion injury by liposomal superoxide dismutase in rats sub-jected to tourniquet shock. AOKI, Y., NATA, M., ODAIRA, T., and SAGISAKA, K., Int. J. Legal Med., 1992, 105, (1), 5–9.
  • Metabolism of vitamin D3 administered into liposomes in the rat liver. APUKHOVSKAYA, L. I., KHRESTOVA, N. L., and ANTONENKO, L. V., Ukr. Biokhim. Zh., 1991, 63, (5), 89–94.
  • The DDT method: an alternative to the use of radiolabelled microspheres for the determina-tion of regional blood flows in the rat. ARGI LES, J. M., ZEGRI, A., and LOPEZ-SORIANO, F. J., Med. Hypotheses, 1992, 37, (4), 268–270.
  • In vitro stability of liposomes in the presence of polymers, trehalose and sodium tauro-cholate. ASSADULLAHI, T. P., HAMID, K., and HIDER, R. C., y. Microencapsulation, 1992, 9, (3), 317–327.
  • The association of human coagulation factors VIII, IXa and X with phospholipid vesicles involves both electrostatic and hydrophobic interactions. ATK1Ns, J. S., and GANZ, P. R., Mol. Cell. Biochem., 1992, 112, (1), 61–71. 0265-2048/93 $10.00 C/ 1993 Taylor & Francis Ltd.
  • Low temperature incorporation of bovine serum albumin into a bead formed macroporous hydrophilic polymer matrix with potential for sustained release. ATKINS, T. W., MCCALLION, R. L., and TIGHE, B. J., J. Biomater. Sci. Polym. Ed., 1992, 3, (3), 261–274.
  • The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits. BADIOLA, N., AL-ANGARY, A. N., and HALBERT, G. W., J. Pharm. Pharmacol., 1992, 44, (4), 366–368.
  • Use of progestrone in microspheres for maintenance of pregnancy in mares. BALL, B. A., WILKER, C., DAELS, P. F., and BURNS, P. J., Am. y. Vet. Res., 1992, 53, (8), 1294–1297.
  • Irradiation increases proteolysis in erythrocyte ghosts: a spin label study. BARTOSZ, G., SCHON, W., KRAFT, G., and GARTNER, H., Radiat. Environ. Biophys., 1992, 31, (2), 117–121.
  • A simple preparatory method for liposomes and the experimental preparation of hemoglobin-and insulin-liposomes. Review of an experimental series on the preparation of parenterally and perorally applied liposomes. BAUER, K. H., Pharm. Unserer. Zeit., 1992, 21, (2), 71–75.
  • Liposomes, membrane fusion, and cytoplasmic delivery. BENTZ, J., ALFORD, D., and ELLENS, H., Struct. Biol. Membr., CRC, Boca Raton, Fla., U.S.A., 1992, pp. 915–947. Ed.: Yeagle, P. L.
  • Effects of photosensitization and low-power helium-neon laser irradiation on liposomes and cell membranes. BERKI, T., NEMETH, P., POTO, L., and NEMETH, A., Scanning Microsc., 1991, 5 (4), 1157–1164.
  • Liposome encapsulation prolongs alfentanil spinal analgesia and alters systemic redistribu-tion in the rat. BERNARDS, C. M., LUGER, T. J., MALMBERG, A. B., HILL, H. F., and YAKSH, T. L., Anesthesiology, 1992, 77, (3), 529–535.
  • Fast and slow kinetics of porin channels from Escherichia coil reconstituted into giant liposomes and studied by patch-clamp. BERRIER, C., COULOMBE, A., HOUSSIN, C., and GHAZI, A., FEBS Lett., 1992, 306, (2-3), 251–256.
  • Immobilization of active urokinase on albumin microspheres: use of a chemical dehydrant and process monitoring. BHARGAVA, K., and ANDO, H. Y., Pharm. Res., 1992, 9, (6), 776–781.
  • Serotonin transport in reconstituted endothelial cell plasma membrane proteoliposomes: effect of hypoxia. BHAT, G. B., and BLocK, E. R., Am. J. Respir. Cell Mol. Biol., 1992, 6, (6), 633–638.
  • Novel detection by magnetic microcapsules in the human gastrointestinal tract of cross-linking agents and diet-dependent reactive oxygen species. BINGHAM, S. A., ELLuL, A., CUMMINGS, J. H., and O'NEILL, I., Carcinogenesis, 1992, 13, (4), 683–690.
  • Control of pro-oxidant activity of cupric ions by entrapment in unilamellar lipid vesicles. BISBY, R. H., MORGAN, C. G., and MUNRO, L. H., Free Radic. Res. Commun., 1992, 16, (1), 65–71.
  • Diminished genotoxicity of mitomycin C and farmorubicin included in poly(butylcyano-acrylate) nanoparticles. BLAGOEVA, P. M., BALANSKY, R. M., MIRCHEVA, T. J., and SIMEONOVA, M. I., Mutat. Res., 1992, 268, (1), 77–82.
  • Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs. BODMEIER, R., WANG, J., and BHAGWATWAR, H., J. microencapsuktion, 1992, 9, (1), 99–107.
  • Process and formulation variables in the preparation of wax microparticles by a melt disper-sion technique.. I. Oil-in-water technique for water-insoluble drugs. BODMEIER, R., WANG, J., and BHAGWATWAR, H., y. mimencapsuiation, 1992, 9, (1), 89–98.
  • Formation and reactivity of the singlet oxygen photosensitized by hypericin in the liposomes of dipalmitoylphosphatidylcholine. Evidence of delayed oxidation. BOUIRIG, H., ELOY, D., and JARDON, P., y. Chim. Phys. Phys.-Chim. Biol., 1992, 89, (6), 1391–1411.
  • Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. BRADY, M. S., RICKARD, K., Yu, P. L., and EIGEN, H. y. Am. Diet. Assoc., 1992, 92, (7), 813–817.
  • Calcium-induced acetylcholine release and intramembrane particle occurrence in proteo-liposomes equipped with mediatophore. BROCHIER, G., GuLIK-KRZYWICKI, T., LESBATS, B., DEDIEU, J., and ISRAEL, M., Biol. Cell (1981), 1992, 74, (2), 225–230.
  • Preparation of spherical polybenzimidazole particulates using a nonaqueous suspension methodology. BROCK, T., and SHERRINGTON, D. C., Polymer, 1992, 33, (8), 1773–1777.
  • Intravascular transplantation of microencapsulated islets in diabetic dogs. CALAFIORE, R., BASTA, G., FALORNI, A. JR, CIABATTONI, P., BROTZU, G., CORTESINI, R., and BRUNETTI, P., Transplant. Proc., 1992, 24, (3), 935–936.
  • Sustained release of nerve growth factor from biodegradable polymer microspheres. CAMARATA, P. J., SURYANARAYANAN, R., TURNER, D. A., PARKER, R. G., EBNER, T. J., Neurosurgery, 1992, 30, (3), 313–319.
  • Molecular packing parameters of bipolar lipids. CAVAGNETTO, F., RELINI, A., MIRGHANI, Z., GLiozzi, A., BERTOIA, D., and GAMBACORTA, A., Biochim. Biophys. Acta, 1992, 1106, (2), 273–281.
  • Generation and characterization of iron- and barium-loaded liposomes. CHAKRABARTI, A. C., VEIRO, J. A., WONG, N. S., WHEELER, J. J., and CuLLis, P. R., Biochim. Biophys. Acta, 1992, 1108, (2), 233–239.
  • Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. CHAKRABARTI, A., MATKO, J., RAHMAN, N. A., BARISAS, B. G., and EDIDIN, M., Biochemistry, 1992, 31, (31), 7182–7189.
  • Lactococcus lactis release from calcium alginate beads. CHAMPAGNE, C. P., GAUDY, C., PONCELET, D., and NEUFELD, R. J., Appl. Environ. Microbiol., 1992, 58, (5), 1429–1434.
  • Magnetic resonance imaging of abscesses using lipid-coated iron oxide particles. CHAN, T. W., ELEY, C., LIBERTI, P., So, A., and KRESSEL, H. Y., Invest. Radiol., 1992, 27, (6), 443–449.
  • Activating hydroxyl groups of polymeric carriers using 4-fluorobenzenesulfonyl chloride. CHANG, Y. A., GEE, A., SMITH, A., and LAKE, W., Bioconjug. Chem., 1992, 3, (2), 200–202.
  • Phenylbutazone action on dimiristoyl phosphatidylcholine liposome phase transition and 8-anilino-1-naphthalene sulfonate binding. CHANTRES, J. R., and SAINZ, M. C., J. Pharm. Sci., 1992, 81, (1), 71–78.
  • Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. CHAVANY, C., LE-DOAN, T., COUVREUR, P., PUISIEUX, F., and HEI,ENE, C., Pharm. Res., 1992, 9, (4), 441–449.
  • Effect of glycolipids on the phase behavior and dynamic properties of phospholipid liposomes. CHEN, J. W., SHI, K., ZHANG, L., and HUANG, F., Biochem. Biophys. Res. Commun., 1992,186, (3), 1294–1298.
  • Evaluation of ion-exchange microspheres as carriers for the anticancer drug doxorubicin: in vitro studies. CHEN, Y., BURTON, M. A., CODDE, J. P., NAPOLI, S., MARTINS, I. J., and GRAY, B. N., y. Pharm. Pharmacol., 1992, 44, (3), 211–215.
  • Microencapsulation of pesticides by interfacial polymerization. 2. Polyamide microcapsules containing water-soluble drug. CHOI-KIL-YEONG, MIN-KVOUNG-SUK, and CHANG-TAI-HYUN, Pollimo, 15, (5), 548–555.
  • Interaction of oxymyoglobin and apomyoglobin with phospholipid vesicles at low pH. CHOI-YOUNG-HO, LEE-JONG-WOO, and KIM-HYOUNGMAN, Mol, Cells, 1992, 2, (1), 75–81.
  • Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. CHONN, A., SEMPLE, S. C., and CULLIS, P. R., J. Biol. Chem., 1992, 267, (26), 18759–18765.
  • Preparation of controlled-release microcapsules containing ketoprofen-beta-cyclodextrin solid dispersions. CHuN-IN-Koo, and PARK-JUNG-HWA, Yakche Hakhoechi, 1992, 22, (1), 33–40.
  • Fluorescence studies of the secondary structure and orientation of a model ion channel peptide in phospholipid vesicles. CHUNG, L. A., LEAR, J. D., and DF,GRADO, W. F. Biochemistry, 1992, 31, (28), 6608–6616.
  • The intestinal and serum humoral immmune response of mice to orally administered antigens in liposomes: H. The response to liposome-entrapped bacterial proteins. CLARK, C. J., and STOKES, C. R., Vet. Immunol. Immunopathol., 1992, 32, (1-2), 139–148.
  • The intestinal and serum humoral immmune response of mice to orally administered antigens in liposomes: I. The response to liposome-entrapped soluble proteins CLARK, C. J., and STOKES, C. R., Vet. Immunol. Immunopathol., 1992, 32, (1-2), 125–138.
  • A sequential mechanism for the information of aqueous channels by amphotericin B in liposomes. The effect of sterols and phospholipid composition. CoHEN, B. E., Biochim. Biophys. Acta, 1992, 1108, (1), 49–58.
  • Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. COLLINS, D. S., FINDLAY, K., and HARDING, C. V., J. .1MMund., 1992, 148, (11), 3336–3341.
  • Fluorescence spectroscopy studies of the effects of pyrethroids on the DPPC vesicles. CONG, R., ZHou, Z., and Liu, Y., Biomed. Environ. Sci., 1992, 5, (2), 109–114.
  • Localised application of an activating signal to a cell: experimental use of fibronectin bound to beads and the implications for mechanisms of adhesion. CURTIS, A. S., MCGRATH, M., and GASMI, L.,/. Cell Sci., 1992, 101, (2), 427–436.
  • Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. CUVIER, C., ROBLOT-TREUPEL, L., MILLOT, J. M., LIZARD, G., CHEVILLARD, S., MANFAIT, M., COUVREUR, P., and POUPON, M. F., Biochem. Pharmacol., 1992, 44, (3), 509–517.
  • In vitro interaction of interferon-alpha-2b with microsphere particles. CZEJKA, M. J., SCHUELLER, J., and MICKSCHE, M., Pharmazie, 1992, 47, (5), 387.
  • Effects of alkyl glycosides incorporated into liposomes prepared from synthetic amphiphiles on their tissue distribution in Ehrlich solid tumor-bearing mice. DAICHO, Y., OKADA, S., and GOTO, 12., Biochim. Biophys. Acta, 1992, 1107, (1), 61–69.
  • Current state of liposome-complexed drugs in the treatment of cancer patients (editorial; comment). DE VRIES, E. G., MULDER, N. H., and DAEMEN, T., Ann Oncol., 1992, 3, (6), 419–421.
  • Liposomes containing fluorinated steroids: an analysis based on photon correlation and fluorine-19 nuclear magnetic resonance spectroscopy. DEVOISSEI,LE, J. M., VION-DRURY, J., CONFORT-GOUNY, S., COUSTAUT, D., and COZZONE, P. J., J. Pharm. Sci., 1992, 81, (3), 249–254.
  • Percolation and release of cisplatin loaded in poly(lactide-co-glycolide) microspheres for chemoembolization. DEYME, M., SPENLEHAUER, G., and BENOIT, J. P., y. Bioact. Compat. Polym., 1992, 7, (2), 149–160.
  • Evaluation of phospholipids in liposomes by HPTLC. DHANESAR, S. C., PEELER, T. R., and ENGEL, B. S., J. Planar Chromatogr.-Mod. TLC, 1992, 5, (1), 45–49.
  • Preparation of a protein-free total brain white matter lipid fraction: characterization of liposomes. DIAZ, R. S., MONREAL, J., REGUEIRO, P., and LUCAS, M., J. Neurosci. Res., 1992, 31, (1), 136–145.
  • Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. DOWNS, E. C., ROBERTSON, N. E., Riss, T. L., and PLUNKETT, M. L., J. Cell Physiol., 1992, 152, (2), 422–429.
  • Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. DRANCOURT, M., GEORGE, F., BROUQUI, P., SAMPOL, J., and RAOULT, D., 7. Infect. Dis., 1992, 166, (3), 660–663.
  • Topical delivery of liposomally encapsulated gamma-interferon. Du PI,ESSIS, J., EGBARIA, K., RAMACHANDRAN, C., and WEINER, N., Antiviral Res., 1992, 18, (3-4), 259–265.
  • Binding of factor Villa and factor VIII to factor IXa on phospholipid vesicles. DUFFY, E. J., PARKER, E. T., MUTUCUMARANA, V. P., JOHNSON, A. E., and LOLLAR, P., y . Biol. Chem., 1992, 267, (24), 17006–17011.
  • Binding of substance P to monolayers and vesicles made of phosphatidylcholine and/or phosphatidylserine. DUPLAA, H., CONVERT, O., SAUTEREAU, A. M., TOCANNE, J. F., and CHASSAING, G., Biochim. Biophys. Acta, 1992, 1107, (1), 12–22.
  • Mixed phospholipid liposome calcification. EANES, E. D., Bone Miner, 1992, 17, (2), 269–272.
  • Adsorption of fluorescein dyes on albumin microspheres. EGBARIA, K., and FRIEDMAN, M., Pharm. Res., 1992, 9, (5), 629–635.
  • Physicochemical properties of albumin microspheres determined by spectroscopic studies. EGBARIA, K., and FRIEDMAN, M., J. Pharm. Sc., 1992, 81, (2), 186–190.
  • Liposomes as a topical drug delivery system evaluated by in vitro diffusion studies. EGBARIA, K., and WEINER, N., Cosmet. Pharm. Appl. Polym., (Proc. Am. Chem. Soc. Symp. Polym. Cosmet. Pharm. Appl.), 1990, Plenum, New York, N.Y., U.S.A., publ. 1991, pp. 215–224. Eds: Gebelein, C. G., Cheng, T. C. and Yang, V. C. M.
  • Penetration kinetics of cis-diamminedichloroplatinum(H) loaded nanoparticles in lipid monolayers as a membrane model of the reticuloendothelial system. EGEA, M. A., ALSINA, M. A., ESPINA, M., VAI,LS, O., and GARCIA, M. L., Thin Solid Films, 1992, 210–211. (1–2), 364–367.
  • Preparation and in vitro evaluation of slow release ketoprofen microcapsules formulated into tablets and capsules. EL-KHODAIRY, K. A., ESHRA, A. G., NADA, A. H., and MORTADA, S. A. M.,1. Microencapsulation, 9, (3), 365–373.
  • The stability and functional properties of proteoliposomes mixed with dextran derivatives bearing hydrophobic anchor groups. ELFER1NK, M. G. L., DE WIT, J. G., IN-T-VELD, G., REICHERT, A., DRIESSEN, A. J. M., RINGSDORF, H., and KON1NGS, W. N., Biochim. Biophys. Acta, 1992, 1106, (1), 23–30.
  • Polymers for biodegradable medical devices. IX: Microencapsulation studies; effects of poly-mer composition and process parameters on poly-hydroxybutyrate-hydroxyvalerate microcapsule morphology. EMBI,ETON, J. K., and TIGHE, B. J., y. Microencapsulation, 1992, 9, (1), 73–87.
  • Lipid vesicles which can bind to protein kinase C and activate the enzyme in the presence of EGTA. EPAND, R. M., STAFFORD, A. R., and LESTER, D. S., Eur. J. Biochem., 1992, 208, (2), 327–332.
  • Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. ESPARZA, I., and KISSEL, T., Vaccine, 1992, 10, (10), 714–720.
  • Microencapsulated antidegradants for extending rubber lifetime. EVANS, L. R., BENKO, D. A., GILLICK, J. G., and WADDELL, W. H., Rubber Chem. Technol., 1992, 65, (1), 201–210.
  • Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. FATUNMBI, O. O., NEWMAN, J. A., SIVANANDAN, V., and HALVORSON, D. A., Vaccine, 1992, 10, (9), 623–626.
  • Interaction of chlorpromazine hydrochloride with cholesterol-inhibiting liposome forma-tion. FETOUH, M. I., AHMED, A. M. S., OMAR, S. M., and EL-RIDY, M. S., Alexandria y. Pharm. Sci., 1992, 6, (1), 89–91.
  • Interaction between cholera toxin conjugated with liposomes and membranes containing GML. FlAccAvENTo, R., BAIOCCH1, M., and TOMASI, M., Zentralbl. Bakteriol., Suppl., 1992, 23 (Bact. Protein Toxins), 190–191.
  • Measurement of carbon clearance in mice as toxicity parameter for liposomal preparations. FicHTNEs, I., KNIEST, A., and ARNDT, D., In Vivo, 1992, 6, (1), 113–117.
  • Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. FIELDING, R. M., SINGER, A. W., WANG, L. H., BABBAR, S., and Guo, L. S., Antimicrob. Agents Chemother., 1992, 36, (2), 299–307.
  • Effect of N-alkyl-N,N,N-trimethylamonium bromides on the autoperoxidation of egg yolk phosphatidylcholine in liposomes. FILIPEK, J., KOVACS, P., and BALGAVY, P., Biochem. Int., 1992, 26, (1), 79–85.
  • Liposomes-model membranes to studh the binding of tricyclic antidepressants. FISAR, Z., KRULIK, R., and BEITLOVA, D., Drug Metabol. Drug Interact., 1991, 9, (3-4), 269–281.
  • An investigation of internal phase losses during the microencapsulation of fragrances. FLORES, R. J., WALL, M. D., CARNAHAN, D. W., and OROFINO, T. A., J. microencapsuiation, 1992, 9, (3), 287–307.
  • Interaction of liposomal drug delivery systems with cells and tissues: microscopic studies. FOLDVARI, M., FAULKNER, G. T., MEzEi, C., and MEZEI, M., Cells Mater., 1992, 2, (1), 67–85.
  • Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres. FORNI, F., VANDELLI, M. A., and CAMERONL, R., J. Microencapsulation, 1992, 9, (1), 29–39.
  • Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. FORSSEN, E. A., COULTER, D. M., and PROFFITT, R. T., Cancer Res., 1992, 52, (12), 3255–3261.
  • MTP-PE in liposomes as a biological response modifier in the treatment of cancer: current status. FROST, H., Biotherapy, 1992, 4, (3), 199–204.
  • Purification and reconstitution of p-opioid receptors in liposome. FUJIOKA, T., 1NouE, F., SUMITA, S., KURIYAMA, M. HANAWA, T., and KATAGI, T., y. Chromatogr., 1992, 597, (1-2), 429–433.
  • Changes in 111-NMR chemical shifts of Bis-GMA and its related methacrylates induced by their interaction with phosphatidylcholine/cholesterol liposomes. FUJISAWA, S., KADOMA, Y., and KOMODA, Y., Dent. Mater. . 7., 1991, 10, (2), 121–127.
  • Tumour-localizing properties of porphyrins. In vivo studies using free, and liposome encapsu-lated aminolevulinic acid. FUKUDA, H., PAREDES, S., and BATLLE, A. M., Comp. Biochem. Physiol, (B), 1992,102, (2), 433–436.
  • Simple gas chromatographic headspace analysis of residual organic solvent in microspheres. GANGRADE, N., and PRICE, J. c.,y. Pharm. Sci., 1992, 81, (2), 201–202.
  • Studies on acetazolamide release from agar microspheres. GARAI, A., DUTTA, A. S., and SA, B., Indian .7. Pharm. Sci., 1992, 54, (2), 59–62.
  • Sensitive procedures for measuring chloride fluxes mediated by the purified glycine receptor incorporated into phospholipid vesicles. GARCIA-CALVO, M., VALDIVIESO, F., MAYOR, F. JR, and VAZQUEZ, J., Neurosci. Lett., 1992, 136, (1), 102–104.
  • Incorporation of new amphiphilic perfluoroalkylated bipyridine platinum and palladium complexes into liposomes: stability and structure-incorporation relationships. GARP:LLI, N., and VIERLING, P., Biochim. Biophys. Acta, 1992, 1127, (1), 41–48.
  • Timolol in lipospheres. GASCO, M. R., CAVALLI, R., and CARLOTTI, M. E., Pharmazie, 1992, 47, (2), 119–121.
  • Optimization of the incorporation of deoxycorticosterone acetate in lipospheres. GASCO, M. R., MOREL, S., and CARPIGNANO, R., Eur. y. Pharm. Biopharm., 1992, 38, (1), 7–10.
  • Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. GASPAR, R., OPPERDOES, F. R., PREAT, V., and ROLAND, M., Ann. Trop. Med. Parasitol., 1992, 86, (1), 41–49.
  • Macrophage activation by polymeric nanoparticles of poly(alkyl cyanoacrylates): activity against intracellular Leishmania donovani associated with hydrogen peroxide production. GASPAR, R., PREAT, V., OPPERDOES, F. R., and ROLAND, M., Pharm. Res., 1992, 9, (6), 782–787.
  • Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF). GAUTIER, J. C., GRANGIER, J. L., BARBIER, A., DUPONT, P., DUSSOSSOY, D., PASTOR, G., and COUVREUR, P., y. Controlled Release, 1992, 20, (1), 67–77.
  • Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. GEHRING, W., GHYCZY, M., GLOOR, M., SC-IEEE, T., and ROEDING, J., Arzneim. Forsch., 1992, 42, (7), 983–985.
  • In vitro binary release kinetics of sulphamethoxazole and trimethoprim microcapsules. GHOSAL, S. K., MAHURI, G., and PAL, T. K., Boll. Chirn. Farm., 1992, 131, (1), 19–21.
  • Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Crypto-coccus neoformans infections in mice. GILBERT, B. E., WYDE, P. R., and WILSON, S. Z., Antimicrob. Agents-Chemother., 1992, 36, (7), 1466–1471.
  • Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). GILBERT, G. E., DRINKWATER, D., BARTER, S., and CLOUSE, S. B., y. Biol. Chem., 1992, 267, (22), 15861–15868.
  • Towards modeling the meniscus geometry and volume of capillary water between two con-tacting microspheres in moist air. GLASSTETTER, R., RICKE.TTS, C. I., and WILHELM, J. G., 9. Aerosol Sci., 1991, 22, (Suppl. 1), S195–S198.
  • Liposome-encapsulated hemoglobin: historical development of a blood substitute. GOINS, B., RuDOLPH, A. S., and LIGLER, F. S., Biotechnol. Ser., 1991, 19 (Biotechnol. Blood), 117–125.
  • Probing actin and liposome interaction of talin and talin-vinculin complexes: a kinetic, thermodynamic and lipid labeling study GOLDMAN, W. H., NIGGL1, V., KAUFMANN, S., and ISENBERG, G., Biochemistry, 1992, 31, (33), 7665–7671.
  • Development of lasers of microspherical polymers. GONOKAM1, M., and TAKEDA, K., Kagaku (Kyoto), 47, (3), 156–161.
  • Preparation of poly 03,11 lactide microspheres by emulsion-solvent evaporation, and their clinical applications as a convenient embolic material. GRANDFILS, C., FLANDROY, P., NIHANT, N., BARRETTE, S., JEROME, R., TEYSSIE, P., and THIBAUT, A., y. Biomed. Mater. Res., 1992, 26, (4), 467–479.
  • Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. GREGORIADIS, G., Res. Immunol., 1992, 143, (2), 178–185.
  • Bone marrows of non-Hodgkin's lymphoma patients with a bc1-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. GRIBBEN, J. G., SAPORITO, L., BARBER, M., BLAKE, K. W., EDWARDS, R. M., GRIFFIN, J. D., FREEDMAN, A. S., and NADLER, L. M., Blood, 1992, 80, (4), 1083–1089.
  • Proteinaceous microspheres. GRINSTAFF, M. W., and SusucK, K. S., ACS Symp. Ser., 1992, 493 (Macromol. Assem. Polym. Syst.), 218–226.
  • The synthesis of surface-functionalized probe-containing nanospheres for bioanalysis. Guo, C., University of Missouri, Columbia, MO, USA, Dissertation, 1991, 178 pp.
  • Anesthesiologic efficacy of propanidid as a liposome dispersion. An experimental study with rats. HABAZETTL, H., VOLLMAR, B., ROHRICH, F., CONZEN, P., DOENICKE, A., and BAETHMANN, A., Anaesthetist, 1992, 41, (8), 448–456.
  • Photostabilization of riboflavin by incorporation into liposomes. HABIB, M. J., and ASKER, A. F., 9. Parenter. Sci. Technol., 1991, 45, (3), 124–127.
  • Influence of the galactosyl ligand structure on the interaction of galactosylated liposomes with mouse peritoneal macrophages., HAENSLER, J., and SuilUBER, F., Glycoconj. 9., 1991, 8, (2), 116–124.
  • Toxicity of a new dosage form, cisplatin incorporated in lactic acid oligomer microspheres, in mice. HAGIWARA, A., TAKAHASHI, T., SASABE, T., ITO, M., LEE, M., SAKAKURA, C., SHOBAYASHI, S., MURANISHI, S., and TASHIMA, S., Anti-Cancer Drugs, 1992, 3, (3), 237–244.
  • In vitro release kinetics of timolol and timolol maleate from poly (ethyl cyanoacrylate) nanoparticles: I. Nanoparticles manufactured with timolol using nonionic surfactants in aqueous medium. HARMIA-PULKKINEN, T ., Acta Pharm. Fenn., 1992, 101, (1), 25–30.
  • Induction of hepatitis A virus antibodies by a synthetic peptide entrapped into liposomes. HARO, I., RABANAL, F., TOBAR, R., GAJARDO, R., REIG, F., BOSCH, A., and GARCIA, A. J. M., Pept 1990, Proc. Eur. Pept. Symp., 21st, 1990, ESCOM Sci. Publ., Leiden, Neth., publ. 1991, pp. 851–852. Eds: Giralt, E. and Andreu, D.
  • Understanding liposomal properties to aid their clinical usage. HARWOOD, J. L., Trends Biochem. Sci., 1992, 17, (6), 203–204.
  • Mutual recognition between polymerized liposomes. IV. Polysaccharide-lectin system. HASEGAWA, M., KAKU, T., KURODA, M., IsE, N., and KITANO, H., Biotechnol. Appl. Biochem., 1992, 15, (1), 40–47.
  • Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. HASSAN, E. E., PARISH, R. C., and GALLO, J. M., Pharm. Res., 1992, 9, (3), 390–397.
  • Preparation of functional polymer microspheres by dispersion polymerization. HATATE, Y., OKAE, T., UEMURA, Y., KAWANO, Y., HATANAKA, C., IDE, S., and HARAGUCHI, T., Kagaku Kogaku Ronbunshu, 1992, 18, (3), 382–385.
  • Antitumor effect of thermosensitive CDDP-liposomes on human osteosarcoma cells in culture. HATTORI, M., MATSUI, N., OHTA, H., OTSUKA, T., YAMADA, K., ASAI, K., and KATO, T., Nippon Seikeigeka Gakkai Zasshi, 1992, 66, (5), 476–484.
  • Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. HAUSELMANN, H. J., AYDELOTTE, M. B., SCHUMACHER, B. L., KUETTNER, K. E., GITELIS, S. H., and THONAR, E. J., Matrix, 1992, 12, (2), 116–129.
  • Liposome-mediated transfer of fusion genes to the intact lung. HAZINSKI, T. A., Semin. Perinatol., 1992, 16, (3), 200–204.
  • Nearly spherical vesicle shapes calculated by use of spherical harmonics: axisymmetric and nonaxisymmetric shapes and their stability. HEINRICH, V., BRUMEN, M., HEINRICH, R., SVETINA, S., and ZEKS, By. Phys., II, 2, (5), 1081-1108.
  • Magnetic beads in suspension enable a rapid and sensitive immunodetection of human placental alkaline phosphatase. HENDRIX, P. G., HOYLAERTS, M. F., NOUWEN, E. J., VAN DE VOORDE, A., and DE BROE, M. E., Eur. J. Clin. Chem. Clin. Biochem., 1992, 30, (6), 343–347.
  • Liposome interactions with hydroxyapatite crystals: a possible mechanism in the calcification of atherosclerotic plaques. HIRSCH, D., LANDis, W. J., AZOURY, R., and SARIG, S., Calcif. Tissue Int., 1992, 50, (3), 261–265.
  • Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea pigs. Ho, R. J. Y., BURKE, R. L., and MERIGAN, T. C., Vaccine, 1992, 10, (4), 209–213.
  • Normalization of the haemostatic plugs of dogs with haemophilia A (factor VIII deficiency) following the infusion of a combination of factor Xa and phosphatidylcholine/phos-phatidylserine vesicles. HONG-Yu, N., and GILES, A. R., Thromb. Haemost., 1992, 67, (2), 264–271.
  • Antioxidant activity of the pyridoindole stobadine in liposomal and microsomal lipid peroxidation. HORAKOVA, 1., BRIVIBA, K., and SIES, H., Chem. Biol. Interact., 1992, 83, (1), 85–93.
  • In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. HOROWITZ, A. T., BARENHOLZ, Y., and GABIZON, A. A., Biochim. Biophys. Ada, 1992, 1109, (2), 203–209.
  • Microtubule dynamics, liposomes and artificial cells: in vitro observation and cellular automata simulation of microtubule assembly/disassembly and membrane morphogenesis. HOTANI, H., LAHOZ, B. R., COMBS, B., HAMEROFF, S., and RASMUSSEN, S., Nanobiology, 1992, 1, (1), 61–74.
  • Heat-induced drug release rate and maximal targeting index of thermosensitive liposome in tumor-bearing mice. IGA, K., OGAWA, Y., and ToGucH1, H., Pharm. Res., 1992, 9, (5), 658–662.
  • Controlled cisplatin delivery system using poly(n,L-lactic acid). IKE, O., SHIMIZU, Y., WADA, R., HYON, S. H., and IKADA, Y., Biomaterials, 1992, 13, (4), 230–234.
  • Synthesis and application of crosslinked particles containing plural voids. Ismi, K., Nippon Gomu Kyokaishi, 1991, 64, (6), 339–345.
  • Core-shell type polymer microspheres prepared from diblock copolymer films. lEmzu, K., and SAITO, R., Polym. Plast. Technol. Eng., 1992, 31, (7-8), 607–633.
  • Marked prolongation of islet xenograft survival (hamster to mouse) by microencapsulation and administration of 15-deoxyspergualin. IWATA, H., TAKAGI, T., and AMEMIYA, H., Transplant. Proc., 1982, 24, (4), 1517–1518.
  • Agarose microcapsule applied in islet xenografts (hamster to mouse). IWATA, H., TAKAGI, T., and AMEMIYA, H., Transplant. Proc., 1992, 24, (3), 952.
  • Agarose for a bioartificial pancreas. IWATA, H., TAKAGI, T., AMEMIYA, H., SHIMIZU, H., YAMASHITA, K., KOBAYASHI, K., and AKUTSU,Biomed. Mater. Res., 1992, 26, (7), 967-977.Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice., IWATA, H., TAKAGI, T., YAMASHITA, K., KOBAYASHI, K., and AMEMIYA, H., Transplant. Proc., 1992, 24, (3), 997.
  • Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice., IWATA, H., TAKAGI, T., YAMASHITA, K., KOBAYASHI, K., and AMEMIYA, H., ansplant. Proc., 1992, 24, (3), 934.
  • Fo nication of cheese with microencapsulated iron. JACKSON, L. S., and LEE, K., Cult. Dairy Prod. 1., 1992, 27, (2), 4–7.
  • Release characteristies of nitrofurantoin-wax microspheres. JAIN, S. K., PANDE, S., VYAS, S. P., and DIXIT, V. K., Indian J. Pharm. Sci., 1991, 53, (6), 226–228.
  • Microencapsulation of indomethacin by complex emulsification. JANI, G. K., CHAUHAN, G. M., GOHEL, NI., and PATEL, J., Indian Drugs, 1992, 29, (10), 450–452.
  • Lipids, liposomes, and rational drug design (editoral; comment). JANOFF, A. S., Lab. Invest., 1992, 66, (6), 655–658.
  • Transport and decarboxylation of liposomal phosphatidylserine: effect of cations. JASINSKA, R., and ZBOROWSKI, J., Biochim. Biophys. Acta, 1992, 1105, (2), 207–212.
  • Kinetics and prophylactic efficacy of increasing dosages of liposome-encapsulated chloroquine after intramuscular injection into mice. KADIR, F., ELING, W. M. C., CROMMELIN, D. J. A., and ZUIDEMA, J., J. Controlled Release, 1992, 20, (1), 47–54.
  • Mercury(2 +) and copper(2 +) are ionophores, mediating chloride/hydroxide exchange in liposomes and rabbit renal brush border membranes. KARNISKI, L., P., J. Biol. Chem., 1992, 267, (27), 19218–19225.
  • Water permeability through multi-lamella lipid membrane of large liposome. KATO, K., and HIRATA, K., Proc. Symp. Solvent Extr., 1991, 291–298.
  • Characteristics of enzymic NAD+-recycling reaction in microcapsule of liquid-surfactant membrane. KATO, K., YAMASAKI, N., and NAKASHIMA, Y., Process Metall., 1992, 7B (Solvent Extr. 1990, Pt. B), 1827–1832.
  • Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacy1-5-fluoro-2'-deoxyuridine from poly(3-hy-droxybutyrate) microspheres. KAWAGUCHI, T., TSUGANE, A., HIGASHIDE, K., ENDOH, H., HASEGAWA, T., KANNO, H., SEKI, T., JuNi, K., FUKUSHIMA, S., and NAKANO, M., J. Pharm. Sci., 1992, 81, (6), 508–512.
  • The effects of polysaccharide chain length in coating liposomes with partial palmitoyl hyaluronates. KAWAGUCHI, Y., MATSUKAWA, K., GAMA, Y., and ISHIGAMI, Y., Carbohydr. Polym., 1992, 18, (2), 139–142.
  • Effect of omega-phenylalkanols on gel to liquid crystalline phase transition of dipal-mitoylphosphatidylcholine liposome membrane. KAWAMURA, H., MANABE, M., YAMASHITA, R., and TOKUNAGA, S., Niihama Kogyo Koto Senmon Gakko Kiyo, Rikogaku-hen, 1992, 28, 79–83.
  • Membrane fusion of influenza virus with phosphatidylcholine liposomes containing viral receptors. KAWASAKI, K., and OHNISHI, S., Biochem. Biophys. Res. Commun., 1992, 186, (1), 378–384.
  • Lyophilization and size control of liposomes entrapping alkaline phosphatase prepared by freeze/thawing method. The effect of additives: sugar, amino acid, protein and water-soluble polymer. KAWASHIMA, Y., HINO, T., TAKEUCHI, H., NIWA, T., and MATSUI, K., STP Pharma. Sci., 1992, 2, (3), 270–278.
  • Hollow microspheres for use as a floating controlled drug delivery system in the stomach. KAWASHIMA, Y., NIWA, T., TAKEUCFII, H., HINO, T., and 'I'm, Y., y. Pharm. Sci., 1992, 81, (2), 135–140.
  • Differential irreversible insertion of protein kinase C into phospholipid vesicles by phorbol esters and related activators. KAZANIETZ, M. G., KRAUSZ, K. W., and BLUMBERG, P. M., J. Biol. Chem., 1992, 267, (29), 20873–20888.
  • Oil-containing microparticles prepared by simple coacervation. KEIPERT, S., and MELEGARI, P., PZ Wiss., 1992, 5, (2), 84–89.
  • Anionic phospholipids are essential for alpha-helix formation of the signal peptide of prePhoE upon interaction with phospholipid vesicles. KELLER, R. C. A., KILLIAN, J. A., and DE KRUIJEF, B., Biochemistry, 1992, 33, (6), 1672–1677.
  • The effect of angiotensin H on tumor blood flow and the delivery of microparticulate cytotoxic drugs., KERR, D. J., GOLDBERG, J. A., ANDERSON, J. R., WILMOTT, N., WIIATELELY, A. T., MCARDLE, C. S., and MCKILLOP, J., Experientia, Suppl, 1992, 61 (Angiogenesis), 339–345.
  • Effect of dimethylsulfoxide on stratum corneum partitioning and efflux of hydrocortisone 21-octanoate from dipalmitoylphosphatidylcholine liposomes. KHAN, Z. U., JAMSHAID, M., and AHMAD, B., Pak. y. Pharm. (Lahore), 1991, 4, (1-2), 51–58.
  • Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato (trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes. KHOKHAR, A. R., AL-BAKER, S., and PEREz-SoLER, R., Anti-Cancer Drugs, 1992, 3, (2), 95–100.
  • Large unilamellar phospholipid vesicles as a model substrate for phospholipase D. KIM-CHANWOO, KOH-EUN-HIE, and CHOI-MYUNG-UN., Bull. Korean Chem. Soc., 1992, 13, (4), 381–384.
  • Interaction of glucagon with artificial lipid bilayer membranes. KIMURA, S., ERNE, D., and SCHWYZER, R., Int. J. Pept. Protein Res., 1992, 39, (5), 431–442.
  • The agglutination of erythrocytes by influenza virus is strongly inhibited by liposomes incorporating an analog of sialyl gangliosides. KINGERY-WOOD, J. E., WILLIAMS, K. W., SIGAL, G. B., and WHITESIDES, G. M., J. Am. Chem. Soc., 1992, 114, (18), 7303–7305.
  • /n vitro testing of rat and porcine islets microencapsulated in barium alginate beads. SIEBERS, U., ZEKORN, T., HORCHER, A., HERING, B., BRETZEL, R. G., ZIMMERMANN, U., and FEDERLIN, K., Transplant. Proc., 1992, 24, (3), 950–951.
  • Temperature induced changes in monomer-dimer distribution of merocyanine 540 in dimyristoyl lecithin liposomes. SIKUROVA, L., and FRANKOVA, R., Stud. Biophys., 1991, 140, (1), 21–28.
  • Effect of different phospholipid-cholesterol membrane compositions on liposome-mediated formation of calcium phosphates. SKRTIC, D., and EANES, E. D., Calcif Tissue Int., 1992, 50, (3), 253–260.
  • Phospholipid vesicles (liposomes) possess the ability to support vascular smooth muscle contractile activity under hypoxia. SOLOV'EV, A. I., BAZILYUK, O. V. STEFANOV, A. V., and LISHKO, V. K., Biol. Membr., 1992, 9, (5), 509–517.
  • Quantitative reconstitution of isolated influenza hemagglutinin into liposomes by the detergent method and the immunogenicity of hemagglutinin liposomes. STAHN, R., SCHAEFER, H., KUNZE, M., MALUR, J., LADHOFF, A., and LACHMANN, U., Acta Virol. (Engl. Ed), 1992, 36, (2), 129–144.
  • Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. STEWART, M. J., PLAUTZ, G. E., DEL BUONO, L., YANG, Z. Y., Xu, L., GAO, X., HUANG, L., NABEL, E. G., and NABEL, G. J., Hum. Gene Ther., 1992, 3, (3), 267–275.
  • Electrooptic observation of the gel-liquid crystalline phase transition in liposomes. STOIMENOVA, M., KoiNOVA, R., KHRISTOVA, I., and TENCHOV, B., .7. Colloid Interface Sci., 1992, 151, (2), 591–593.
  • Synthesis of polymerized preceramic nanoparticle powders by laser irradiation of metal-organic precursors. STRUTT, P. R., GONSALVES, K. E., and XLNO, T. D., Nanostruct. Mater., 1992, 1, (1), 21–25.
  • Liposomes in the treatment of malignancy: a clinical perspective. SUGARMAN, S. M., and PEREZ-SOLER, R., Crit. Rev. Oncol. Hernatol., 1992, 12, (3), 231–242.
  • On the mechanism by which bupivacaine conducts protons across the membranes of mitochondria and liposomes. SUN-XIAOCHENG, and GARLID, K. D., y. Biol. Chem., 1992, 267, (27), 19147–19154.
  • Artesunate liposomes. SUN-YUEGIN, and XIE-XINGHUI, Zhongguo Yiyao Gongye Zazhi, 1992, 23, (2), 69–72.
  • A water-soluble spin probe newly developed for liposomal studies. SUNAMOTI, J., AKIYOSHI, K., KIHARA, T., and ENDO, M., Bull. Chem. Soc. jpn., 1992, 65, (4), 1041–1046.
  • Direct transfer of membrane proteins from B16 melanoma cell to artificial cell liposome. SUNAMOTO, J., MORI, Y., and SATO, T., Proc. jpn. Acad., Ser. B, 1992, 68, (5), 69–74.
  • Direct transfer of tumor surface antigenic protein (TSAP) from tumor cell to liposome for making liposomal vaccine. SUNAMOTO, J., NOGUCHI, T., SATO, T., AKIYOSHI, K., SHIBATA, R., NAKAYAMA, E., and SHIKU, H., y. Controlled Release, 1992, 20, (2), 143–153.
  • Liposome-type artificial red blood cells. Suzum, K., Bio. Ind., 1992, 9, (5), 290–296.
  • Naproxen microcapsules: preparation and in vitro characterization. SVEINSSON, S. J., and KRISTMUNDSDOTTIR, T., Int. y. Pharm., 1992, 82, (1-2), 129–133.
  • Glycation of lens MIP26 affects the permeability in reconstituted liposomes. SWAMY, M. S., and ABRAHAM, E. C., Biochem. Biophys. Res. Commun., 1992, 186, (2), 632–638.
  • Phagocytosis of liposomes that mimic lipid composition of senescent and sickle erythrocytes. SYMES, M. A., and PATEL, H. M., Biochem. Soc. Trans., 1992, 20, (4), 327S.
  • Preparation of liposomes with vitamins A and E. SZULC, J., WOYCZIKOWSKI, B., SZCZEPANSKA, M., SOSADA, M., and PASKER, B., Pharmazie, 1992, 47, (5), 386–387.
  • Functional signal peptide reduces bilayer thickness of phosphatidylcholine liposomes. TAHARA, Y., MURATA, M., OHNISHI, S., FUJIYOSHI, Y., KIKUCHI, M., and YAMAMOTO, Y., Biochemistry, 1992, 31, (37), 8747–8754.
  • Stimulus-specific enhancement of luminol chemiluminescence in neutrophils by phos-phatidylserine liposomes. TAKAHASHI, M., IKEDA, H., SATO, E. F., AKIMARU, K., EDAMATSU, R., INOUE, M., and UTSUMI, K., Arch. Biochem. Biophys., 1992, 298, (1), 43–48.
  • Action of fatty acid esters of L-ascorbic acid as antioxidants in phosphatidylcholine liposomal membranes. TAKAHASHI, M., KOMURO, E., NIKI, E., and TANAKA, K., Bull. Chem. Soc. ipn., 1992, 65, (3), 679–684.
  • Laser from polymer microspheres. TAKEDA, K., and GONOKAMI, M., Kagaku to Kogyo, 1992, 45, (6), 1110–1113.
  • Effect of morphological properties on drug release from biodegradable microspheres. TAKESHIMA, K., SUNAGAWA, N., NAGATA, S., HIRANO, K., and TAKAGISHI, Y., Yakugaku Zasshi, 1992, 112, (3), 203–210.
  • Destabilization of whole skin lipid bio-liposomes induced by skin penetration enhancers and FT-IR/ATR (Fourier transform infrared/attenuated total reflection) analysis of stratum corneum lipids. TAKEUCHI, Y., YASUKAWA,YAMAOKA, Y., MORIMOTO, Y., NAKAO, S.,FUKUMORI, Y., and FUKUDA, T., Chem. Pharm. Bull.„ 1992, 40, (2), 484–487.
  • The cryopreservation of liposomes. 2. Effect of particle size on crystallization behavior and marker retention. TALSMA, H., VAN STEENBERGEN, M. J., and CROMMELIN, D. J., Cryobiology, 1992, 29, (1), 80–86.
  • Erythrocyte based delivery system of primaquine: in vitro characterization. TALWAR, N., and JAN, N. K., 7. Microencapsulation, 1992, 9, (3), 357–364.
  • Recombinant human tumor necrosis factor-beta entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro. TAN, L., GOH, C. R., and PORTER, A. G., Ypn. 7. Pharmacol., 1992, 59, (2), 235–238.
  • Sensitivity of human melanoma cells in vitro to retinoic acid incorporated in liposomes. TARASIUK, A., Arch. Immunol. Ther. Exp., 1991, 39, (3), 279–284.
  • Thermodynamic method of B/A analysis of liposome suspensions: prediction via single relaxation theory. TATA, D. B., and DUNN, F., y. Ultrasound Med., 1992, 11, (8), 441–447.
  • Inhibitory effect of lentinan entrapped in liposomes on pulmonary metastasis in rats. Distribution of liposomes and enhancement of NK cell activity. TAZAWA, K., KOWAGOSHI, T., YAMASHITA, I., OKAMOTO, M., FUJIMAKI, M., OCHIAI, H., MAEDA, M., and HONDA, T „ Y. Exp. Clin. Cancer Res., 1992, 11, (1), 21–28.
  • The effect of lipase on the release of naltrexone from triglyceride-coated cellulose acetate phthalate microspheres. TEFFT, J. A., RosKos, K. V., and HELLER, J., Y. Biomed. Mater. Res., 1992, 26, (6), 713–724.
  • Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the con-trolled release of pharmaceuticals. THAN00, B. C., SUNNY, M. C., and JAYAKRISHNAN, A., 7. Pharm. Pharmacol., 1992, 44, (4), 283–286.
  • Relationships between manufacturing parameters and pharmaceutical-technological requirements for biodegradable microparticles. Part 5: Relationships between manufacturing parameters, surface properties and degradation characteristics. THOMA, K., and SCHLUETERMANN, B., Pharmazie, 1992, 47, (5), 368–373.
  • Relationships between manufacturing parameters and pharmaceutical-technological requirements for biodegradable microparticles. 2. Preparation of injectable micro-particles in biodegradable polyester. THOMA, K., and SCHLUETERMANN, B., Pharmazie, 1992, 47, (2), 115–119.
  • Relationships between manufacturing parameters and pharmaceutical-technological requirements for biodegradable microparticles. Part 4: Relations between drug loading, matrix properties and manufacturing parameters. THOMA, K., and SCHLUETERMANN, B., Pharmazie, 1992, 47, (4), 269–272.
  • Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidation. THOMAS, C. E., MCLEAN, L. R., PARKER, R. A., and OHLWEILER, D. F., Lipids, 1992, 27, (7), 543–550.
  • Polyelectrolyte-sensitized phospholipid vesicles. THOMAS, J. L., and TIRRELL, D. A., Acc. Chem. Res., 1992, 25, (8), 336–342.
  • Transfer of liposomes containing dolichol into isolated hepatocytes. Tou,Bom, O., CHOJNACKI, T., and DALLNER, G., Lipids, 1992, 27, (4), 248–254.
  • Influence of membrane fluidity on the assembly of Staphylococcus aureus alpha-toxin, a channel-forming protein, in liposome membrane. TOMITA, T., WATANABE, M., and YASUDA, T y . Biol. Chem., 1992, 267, (19), 13391–13397.
  • Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. TORCHILIN, V. P., KLIBANOV, A. L., HUANG, L., O'DONNELL, S., NOSSIFF, N. D., and KHAW, B. A., FASEB y., 1992, 6, (9), 2716–2719.
  • Interaction between oleic acid-containing pH-sensitive and plain liposomes. Fluorescent spectroscopy studies. TORCHILIN, V. P., LUKYANOV, A. N., KLIBANOV, A. L., and OMELYANENKO, V. G., FEBS Lett., 1992, 305, (3), 185–188.
  • Dyphylline liposomes for delivery to the skin. Touvrou, E., SHACO, E. N., DAYAN, N., JUSHYNSKI, M., RAFAELOFF, R., and AZOURY, R., Y. Pharm. Sci., 1992, 81, (2), 131–134.
  • Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles. TROSTER, S. D., and KREUTER, J., 7. Microencapsulation, 1992, 9, (1), 19–28.
  • Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(L-lysine)-antibody conjugate in mouse lung endothelial cells. TRUBETSKOY, V. S., TORCHILIN, V. P., KENNEL, S., and HUANG, L., Biochitn. Biophys. Acta, 1992, 1131, (3), 311–313.
  • Regulation of the tetracycline hydrochloride release from polyacrylate microspheres. Part 1. TSANKOV, S., LAMBOPV, N., and MINKOV, E., Pharmazie, 1992, 47, (2), 125–128.
  • Lipid microsphere containing lipophilic heme: preparation and oxygen transportation under physiological conditions. TSUCHIDA, E., NISHIDE, H., KOMATSU, T., YAMAMOTO, K., MATSUBUCHI, E., and KOBAYASHI, K., Biochim. Biophys. Acta, 1992, 1108, (2), 253–256.
  • Preparation of ruthenium dioxide-silica gel composite microspheres from silicon ethoxide complex dispersion. Tsuvum, M., OMOR1, S., and SENNA, My. Mater. Sci., 1992, 27, (15), 4045–4050.
  • Utility of mixture of commercially available polymers as constituents of sustained-release microcapsules containing cefadroxil or theophylline. UCHIDA, T., YASUTAKE, T., and GOTO, S., Chem. Pharm. Bull., 1992, 40, (2), 463–466.
  • Echinostoma paraensei and Schistosoma mansoni: adherence of unaltered or modified latex beads to hemocytes of the host snail Biomphalaria glabrata. UCHIKAWA, R., and LOKER, E. S., Exp. Parasitol., 1992, 75, (2), 223–232.
  • Clearance of liposomal gadolinium: in vivo decomplexation. UNGER, E. C., FRITZ, T. A., TILCOCK, C., and NEW, T. E., y. Magn. Reson. Imaging, 1991, 1, (6), 689–693.
  • Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsu-lated in long circulating liposomes. VAAGE, J., MAYHEW, E., LASIC, D., and MARTIN, F., Int. J. Cancer, 1992, 51, (6), 942–948.
  • Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R, R-1,2-diaminocyclo-hexane platinum(II) and cisplatin given i.v. and i.p. in the rat. VADIEI, K., SIDDIK, Z. H., KHOKHAR, A. R., AL-BAKER, S., SAMPEDRO, F., and PEREZ-SOLER, R., Cancer Chemother. Pharmacol., 1992, 30, (5), 365–369.
  • Characterization of monoclonal antibodies physically adsorbed onto polystyrene latex particles. VAN ERP, R., LINDERS, Y. E., VAN SOMMEREN, A. P., and GRIBNAU, T. c.,y. Immunol. Methods, 1992, 152, (2), 191–199.
  • The effect of the cross-linking time period upon the drug release and the dynamic swelling of gelatin rnicrospheres. VANDELLI, M. A., FORM, F., COPPL, G., and CAMERONI, R., Pharmazie, 1991, 46, (12), 866–869.
  • In vivo potentiation of ricin toxicity by monensin delivered through liposomes. VASANDANI, V. M., MADAN, S., and GIIOSH, P. C., Biochim. Biophys. Acta, 1992, 1116, (3), 315–323.
  • Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages. VERMA, J. N., RAO, M., AMSAELEM, S., KRZYCH, U., ALVING, C. R., GREEN, S. J., and WASSEF, N. M., Infect. Immun., 1992, 60, (6), 2438–2444.
  • Determination of the partition of the tetramisole derivative ( )-5,6-dihydro-6-pheny1-2-n-propyl-imidazo(2,1-b)thiazole into liposomal membranes by fluorescence quenching of the membrane probe 8-(2-anthry1)-octanoic acid. VERMEIR, M., and BOENS, N. Eur. Biophys. y., 1992, 21, (1), 47–56.
  • Modelling of interaction of basic lipophilic ligands with cytochrome P-450 reconstituted in liposomes. Determination of membrane partition coefficients of S-( - )-nicotine and N,N-diethylaniline from spectral binding studies and fluorescence quenching. VERMEIR, M., BOENS, N., and HEIRWEGH, K. P., Biochim. Biophys. Acta, 1992, 1107, (1), 93–104.
  • Interaction of 7-n-alkoxycoumarins with cytochrome P-4502 and their partitioning into lipo-somal membranes. Assessment of methods for determination of membrane partition coefficients. VERMEIR, M., BOENS, N., and HEIRWEGH, K. P.M.,Biochem. y., 284, (2), 483–490.
  • Microencapsulation of solid dispersions: release of griseofulvin from griseofulvin-phospho-lipid coprecipitates in microspheres. VUDATHALA, G. K., and RocEas, J. A., Pharm. Res., 1992, 9, (6), 759–763.
  • Polymeric pseudolatexes bearing pilocarpine for controlled ocular delivery. VYAS, S. P., RAMCHANDRAIAH, S., JAIN, C. P., and JAIN, S. K., J. Microencapsulation, 1992, 9, (3), 347–355.
  • Drug encapsulation in alginate microspheres by emulsification. WAN, L. S. C., HENG, P. W. S., and CHAN, L. W., J. Microencapsulation, 1992, 9, (3), 309–316.
  • Plasticizers and their effects on microencapsulation process by spray-drying in an aqueous system. WAN, L. S. C., HENG, P. W. S., and CHIA, C. G., y. Microencapsulation, 1992, 9, (1), 53–62.
  • Controlled release of protein and vaccines from poly(ester) microspheres in vitro. WANG, H. T., PALMER, H., LINHARDT, R. J., FLANAGAN, D. R., and SCHMITT, E., Cosmet. Pharm. Appl. Poly. (Proc. Am. Chem. Soc. Symp. Polym. Cosmet. Pharm. Appl.), 1990, Plenum, New York, N.Y., U.S.A., publ. 1991, pp. 239–253. Eds: Gebelein, C. G., Cheng, T. C. and Yang, V. C. M.
  • Protection against acute oxygen toxicity by liposome-entrapped superoxide dismutase. WANG-WENJUN, SHI-CANFU, FANG-DEEN, Z1ANG-LIUBAO, XIAN-QIUSHANG, LI-CHANGLIANG, and HE-Yuxut-t, Zhonghua Laodong Weisheng Zhiyebing Zazhi, 1992, 10, (2), 82–84.
  • An approach to the preparation of digestive enzyme-drug for oral administration: enteric-soluble disaccharidase microcapsules. WANG, X., Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, 1992, 14, (2), 155–158.
  • Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. WARREN, L., JARDILLIER, J. C., MALARSKA, A., and AKELI, M. G., Cancer Res., 1992, 52, ((I), 3241–3245.
  • Pharmacokinetics of cisplatin-ethyl cellulose microspheres for maxillary arterial emboliza-tion in dogs. WEI, S. L., Qi, X. R., and YANG, J., Yaoxue Xuebao, 1992, 27, (5), 381–384.
  • Protective effect of alpha-tocopherol in carrier liposomes on ultraviolet-mediated human epidermal cell damage in vitro. WERNINGHAUS, K., HANDJANI, R. M., and GILCHREST, B. A., Photodermatol. Photoimmunol. Photomed., 1991, 8, (6), 236–242.
  • Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. WETZI,ER, L. M., BLAKE, M. S., BARRY, K., and GOTSCHLICH, E. C., y. Infect. Dis., 1992, 166, (3), 551–555.
  • Doxorubicin-loaded casein microspheres: protean nature of drug incorporation. WILLMOTT, N., MAGEE, G. A., CUMMINGS, J., HALBERT, G. W., and SMYTH, J. F., J. Pharm. Pharmacol., 1992, 44, (6), 472–475.
  • Microencapsulated bovine chromaffin cells in vitro: effect of density and coseeding with a NGF-releasing cell line. WINN, S. R., TRESCO, P. A., ZIELINSKI, B., SAGEN, J., and AF,BISCHER, P., y. Neural. Transplant. Plast., 1992,3, (2-3), 115–124.
  • Phase transition of zeaxanthin modified dimyristoyl phosphatidylcholine liposomes as monitored by acoustic measurements. WOJTOW1CZ, K., GRUSZECKI, W. I., OKULSKI, W., JUSZKIEW1CZ, A., ORZECHOWSKI, A., and GAWDA, H., Stud. Biophys., 1991, 140, (2), 115–120.
  • Sterically stabilized liposomes. WOODLE, M. C., and LAsIc, D. D., Biochim. Biophys. Acta, 1992, 1113, (2), 171–199.
  • Determination of electric field threshold for electrofusion of erythrocyte ghosts. Comparison of pulse-first and contact-first protocols. Wu, Y., MONTES, J. G., and SJODIN, R. A., Biophys. y., 1992, 61, (3), 810–815.
  • Chemoembolic therapy with cisplatin microspheres. XING-JUNFEN, AO-BINGCHEN, LIU-YAXIN, and AO-GuokuN, Zhongguo Yiyuan Yaoxue Zazhi, 1991, 11, (12), 554–556.
  • Association of alpha-phosphatidylinositol-specific phospholipase C with phospholipid vesicles. XU-CHONGJUN, and NEI,SESTUEN, G. L., Biochim. Biophys. Acta, 1992, 1120, (1), 49–58.
  • Application of microcapsules in adhesives. XU-GEWEN, and XU-HONG, Huaxue Yu Nianhe, 1991, (4), 239–241.
  • The antitumor effect of polyphase liposome of linoleic acid containing selenium. XUE-SHAOAN, LI-BAOLIN, WANG-ZHONGHUI, LU-DENGSI, and TAO-JINGYI, Yingyang Xuebao, 1992, 14, (1), 54–57.
  • Preparation of Eudragit RS microcapsule containing ketoprofen and its application to suppositories. YAMABE, K., MIYAKAWA, T., UCHIDA, T., KIM, N. S., and GOTO, S., Yakuzaigaku, 1992, 52, (1), 51–58.
  • Freezing behavior of microencapsulated water. YAMANE, H., OHSHIMA, H., and KONDO, T., 7. Microencapsulation, 1992, 9, (3), 279–286.
  • Species specifity in differences on complement activation by cetylmannoside-modified lipo-somes in fresh plasma. YAMASHITA, C., FUNATO, K., KAMADA, J., YODA, R., and KIWADA, H., Drug Delivery Syst., 1992, 7, (3), 165–168.
  • Phase transitions of phospholipid vesicles under osmotic stress and in the presence of ethylene glycol. YAMAZAKI, M., OHSHIKA, M., KASHIWAGI, N., and ASANO, T., Biophys. Chem., 1992, 43, (1), 29–37.
  • Preparation of neoglycoprotein-bearing liposomes and their interaction with cells and tissues. YAMAZAKI, N., KOJIMA, S., GABIUS, S., and GABIUS, H. J., Lectins Cancer, Springer, Berlin, Germany, 1991, pp. 251–261. Eds:Gabius, H. J. and Gabius, S.
  • Experimental canine maxillofacial arterial embolization with ethylcellulose microspheres. YANG, J., Chung Hua Kou Chiang Hsueh Tsa Chih, 1992, 27, (1), 23–26.
  • Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model. YANO, T., PINSKI, J., SZEPESHAZI, K., MILOVANOVIC, S. R., GROOT, K., and SCHALLY, A. V., Prostate, 1992, 20, (4), 297–310.
  • Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. YAROSH, D., ALAS, L. G., YEE, V., OBERYSZYN, A., KIBITEL, J. T., MITCHELL, D., ROSENSTEIN, R., SPINOWITZ, A., and CITRON, M., Cancer Res., 1992, 52, (15), 4227–4231.
  • Inhibition of Sendai virus fusion and phospholipid vesicle fusion: implications for the pathway of membrane fusion. YEAGLE, P. L., KELSEY, D. R., FLANAGAN, T. D., and YOUNG, J., Cell Model Membr. Interact. (Proc. Symp.), 1990, Plenum, New York, N.Y., U.S.A., publ. 1991, pp. 163–177. Ed.: Ohki, Shinpei.
  • Anticonvulsant effect of liposome-entrapped superoxide dismutase in amygdaloid-kindled rats. YOKOYAMA, H., MORI, N., OSONOE, K., ISHIDA, S., and KUMASHIRO, H., Brain Res., 1992, 572, (1-2), 273–275.
  • Fusion of phospholipid vesicles induced by an amphiphilic model peptide: close corre-lation between fusogenicity and hydrophobicity of the peptide in an alpha-helix. YOSHIMURA, T., GOTO, Y., and AIMOTO, S., Biochemistry, 1992, 31, (26), 6119–6126.
  • Metabolic fate of (I4C)triglyceride-entrapped lactosylceramide-bearing liposomes after intravenous injection into mouse. YOSHIOKA, S., BANNO, Y., OKANO, Y., OHKI, K., and MIZUKAMI, Y., Chem. Pharm. Bull., 1992, 40, (4), 1016–1021.
  • The role of liposomal phospholipid membrane in the modulation of the functional activity of thrombocytes. ZAKREVSKII, V. I., and KIBATIEV, A. A., Biol. Membr., 1992, 9, (6), 617–621.
  • Reconstitution of functional water channels in liposomes containing purified red cell CHIP28 protein. ZEIDEL, M. L., AMBUDKAR, S. V., SMITH, B. L., and ACRE, P., Biochemistry, 1992, 31, (33), 7436–7440.
  • Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. ZEKORN, T., SIEBERS, U., HORCHER, A., SCHNETTLER, R., KLOECK, G., BRETZEL, R. G., ZIMMERMANN, U., and FEDERLIN, K., Transplant. Proc., 1992, 24, (3), 937–939.
  • Alginate coating of islets of Langerhans: in vitro studies on a new method for microencapsu-lation for immuno-isolated transplantation. ZEKORN, T., SIEBERS, U., HORCHER, A., SCHNETTLER, R., ZIMMERMANN, U., BRETZEI„ R. G., and FEDERLIN, K., Acta Diabetol., 1992, 29, (1), 41–45.
  • Application of the liposome technique on protoplast fusion. ZHANG-ZENGD1, WANG-J1ANHUA, ZHU-BAOCHENG, LI-LUBIN, and LI-QINGYU, Hebei Daxue Xuebae, Ziran Kexueban, 1991, 11, (1), 37–40.
  • Liposome as a drug-carrier, potentiates the depressor effect of brain natriuretic peptide. ZHAO-JING, TONG-LIJIA, ZHANG-SUNXI, LI-CHUNYING, TANG-CHAOSHU, and TANG-DAN, Beijing Yike Daxue Xuebao, 1991, 23, (4), 313–315.
  • Regulatory role of GM3 ganglioside in integrin function, as evidenced by its effect on function of alpha 5 beta 1-liposomes: a preliminary note. ZHENG, M., TSURUOKA, T., Tsup, T., and HAKOMORI, S., Biochem. Biophys. Res. Commun., 1992, 186, (3), 1397–1402.
  • Ultrastructure of liposomes (interliposomal bonds). ZHUKOV, V. G., GRIAZNOVA, N. S., TURSUNOVA, E. SH., PETIUSHENKO, R. M., and BELIAVSKAIA, I. V., Antibiot. Khimioter., 1992, 37, (2), 15–17.
  • Investigation of temperature sensitive liposome encapsulated adriamycin injected into hepatic artery for targeted behavior and cancer therapy. Zou, Y. Y., Gu, X. Q., UENO, M., and HORIKOSHI, I., Yao Hsueh Hsueh Pao, 1991, 26, (9), 705–709.
  • Targeting liver tumors by administering liposomal doxorubicin into the hepatic artery. Zou, Y., HORIKOSHI, I., UENO, M., Gu, X., and PEREZ-SOLER, R., Int. J. Cancer, 1992, 51, (2), 232–237.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.